1973
DOI: 10.1002/jps.2600620621
|View full text |Cite
|
Sign up to set email alerts
|

Biophasic Availability of Ophthalmic Carbachol I: Mechanisms of Cationic Polymerand Surfactant-Promoted Miotic Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

1974
1974
2014
2014

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Marsh and Maurice 3) reported that the concentration of fluorescein in the aqueous humor of humans was enhanced by the instillation of dye with a non-ionic surfactant. Smolen et al 4) demonstrated that various preservatives or cationic polymers enhanced carbachol permeability and increased drug concentration inside the eye globe. Newton et al 5) reported that Azone, a transdermal absorption enhancer, increased the ocular delivery of instilled cyclosporine and enhanced immunosuppression activity.…”
mentioning
confidence: 99%
“…Marsh and Maurice 3) reported that the concentration of fluorescein in the aqueous humor of humans was enhanced by the instillation of dye with a non-ionic surfactant. Smolen et al 4) demonstrated that various preservatives or cationic polymers enhanced carbachol permeability and increased drug concentration inside the eye globe. Newton et al 5) reported that Azone, a transdermal absorption enhancer, increased the ocular delivery of instilled cyclosporine and enhanced immunosuppression activity.…”
mentioning
confidence: 99%
“…The mechanism of the microbiocidal action of BAC is thought to be due to disruption of the cell membranes of microorganisms. BAC has also been reported to enhance drug penetration and improve topical bioavailability of ophthalmic drugs [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
“…The mechanism of its microbiocidal action involves the disruption of the cell membranes of microorganisms. 2,3 BAK can potentially increase the delivery of topically applied drugs to the aqueous humor (AH) and, ultimately, to the sites of AH production and outflow. 4 It is most often used at a concentration of 0.01% (ranging from 0.004% to 0.02%) in ophthalmic preparations.…”
mentioning
confidence: 99%